freerober,since you are good in physics answer quickly....at what temperature farenheit and celcius coincide?
hwsimpson.....I think we may have data for aacld pretty soon....as difficult to cure as the other rare diseases just smaller market....
He said they injected patients in sickle cell....not only one. and then he said: it may sound crazy but we are shooting for a cure....updates this year...to the moon Alice.
No....the reason for the time slot was that sarepta did not want to pay the fees for a regular presentation....
Tredleon,if there is anyone who really gets it,it is you.....I do not know your background but you are the smartest guy this board has ever seen...sorry starfe you come third....after greyzone.....the sarepta case reminds me of dendreon...fda delays everything until something better comes along....new competitors must be around the corner that most are unaware of....who could that be?...I am not currently a shareholder but I really pray for the best outcome.....it is not that Chris tried to blackmail the FDA using the popularity of etteplirsen...It is in my opinion that if the FDA was free of outside influence it would have approved this drug already...o tempora o mores.
Good....I am curious about the progress and possible near term news on Ccald.....that could add at least 30 bucks to the share price.....in combo with additional beta news we could see 200 dollars pps by June....and with the first patient on sickle cell cured 300 dollars...I know you think my numbers are exuberant but I call it the way I see it....by the end of the year we will get bought....what most do not comprehend is that bluebird likely will show cures on three different rare diseases....something unheard of any other company in the universe...unfortunately the buyout price will be no more than 500 bucks.
Today is before 2016..... After positive release of few sickle cell cures bluebird will be bought.....do you like 400 dollars as a buyout price or you think is not even close to its real value...come on man...is not how much the pps should be today..it is how much the company worth based on what we know...period.
Nah.....competitors like SGMOs fans use those claims about possible future side effects to instill fear....because they left in the dust.....anyone can claim anything....in between let's have some spectacular cures for people in need and some extra money in our pockets.
40.000 kids born every year with beta tha.....there is a huge worldwide market....no one million one time payment ...most likely 300.000 per year in USA...half that for the rest of the world...the market value of this disease worth more than ten billion for blue....
Of at least two billion per year revenue on beta thalassemia equals to ten billion dollars.....we should be at almost 400 bucks right now just for beta tha......heavily discounted numbers.....blue is the most undervalued biotech in the market....do not let the 95 dollars pps fool you...it is just the start of a meteoric rise that will end up to the stratosphere....think of it as a one dollar stock on its way to ten soon.....sickle cell cure will end up to a buyout.....at what price you should ask celgene......and the worries start ....blue solved the delivery issue....huge unmet market needs in multiple indications....I am afraid that I sound like a pumper....so...I will stop here.
They are....they tend to announce later than any other....sometimes they forget to even tell that their recent dilution has been successfully completed....they do not care....I like it.
correct....but how much BLUE worth just for the beta thalassemia cure?...I am sure a lot more than two and a half billion....and the cash in hand of more than half billion dollars makes bluebird a cheap stock.
..it's all about delivery....seems bluebird got it right.....juno and kite too but the CAR T field is already crowded...BLUE deserves higher valuation since yesterday.
..I would own more bluebird than any other company....they got a piece on CAR T anyway.....but who else will get a piece on beta tha..and sickle cell if blue has the cure?...all the big pharmas including NOV are greatly involved in CAR T and there are patent issues between Novartis and juno...maybe KITE's patent portfolio for the same reason is vulnerable....all companies mentioned have the same market caps...I like blue the most especially it's delivery vehicle....if I had to own one company in the CAR T space it would be BLCM because they got something no one else has.
...for sure in june.....earlier updates possible....don't underestimate the impact in the pps by additional updates from beta tha....it could drive the stock to much higher levels.